{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:07:06Z","timestamp":1790417226162,"version":"4.1.0"},"reference-count":32,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,7,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The current World Health Organization (WHO) classification of hematopoietic malignancies defines several types of mature T-cell leukemia including T-cell prolymphocytic leukemia (T-PLL), Sezary syndrome (SS), and T-cell large granular lymphocytic (T-LGL) leukemia. These neoplasms can show overlapping features with each other and with T-cell lymphomas involving peripheral blood (PB). We analyzed the spectrum of clinicopatho-logic features in 102 mature T-cell leukemias and compared them to 10 hepatosplenic T-cell lymphomas that involved PB. T-PLL, defined as a T-cell leukemia showing rapidly rising PB lymphocyte counts, was the only tumor type expressing the oncoprotein TCL1 (71% of cases) and could present with relatively low lymphocyte levels or small tumor cell morphology. SS, defined by accompanying erythrodermic skin disease, was frequently associated with peripheral eosinophilia but could also develop high numbers of prolymphocytes, especially late in the disease course. T-LGL leukemia, defined by accompanying cytopenias or autoimmune phenomena (or both), had the best clinical outcome and generally showed the lowest circulating lymphocyte levels with only a few cases developing marked lymphocytosis. Using the dominant clinical or phenotypic feature, we describe here the degree of overlap among currently recognized WHO categories and identify areas where further clarification is needed. Our results indicate that incorporation of additional criteria, such as TCL1 expression status and hematologic parameters, can assist in a more accurate classification. (Blood. 2004;104:328-335)<\/jats:p>","DOI":"10.1182\/blood-2004-01-0002","type":"journal-article","created":{"date-parts":[[2004,3,29]],"date-time":"2004-03-29T20:13:04Z","timestamp":1080591184000},"page":"328-335","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":175,"title":["A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories"],"prefix":"10.1182","volume":"104","author":[{"given":"Marco","family":"Herling","sequence":"first","affiliation":[{"name":"From the Departments of Hematopathology, Dermatology, and Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Khoury","sequence":"additional","affiliation":[{"name":"From the Departments of Hematopathology, Dermatology, and Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LaBaron T.","family":"Washington","sequence":"additional","affiliation":[{"name":"From the Departments of Hematopathology, Dermatology, and Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Duvic","sequence":"additional","affiliation":[{"name":"From the Departments of Hematopathology, Dermatology, and Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Keating","sequence":"additional","affiliation":[{"name":"From the Departments of Hematopathology, Dermatology, and Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Jones","sequence":"additional","affiliation":[{"name":"From the Departments of Hematopathology, Dermatology, and Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021223594809300_REF1","unstructured":"Jaffe ES, Harris N, Stein H, Vardiman JW. Tumours of Hematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. Lyon, France: IARC Press; 2001."},{"key":"2020021223594809300_REF2","doi-asserted-by":"crossref","unstructured":"Hoyer JD, Ross CW, Li CY, et al. True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases. Blood.1995;86: 1163-1169.","DOI":"10.1182\/blood.V86.3.1163.1163"},{"key":"2020021223594809300_REF3","doi-asserted-by":"crossref","unstructured":"Garand R, Goasguen J, Brizard A, et al. Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia. Groupe Francais d'Hematologie Cellulaire. Br J Haematol.1998; 103: 488-494.","DOI":"10.1046\/j.1365-2141.1998.00977.x"},{"key":"2020021223594809300_REF4","doi-asserted-by":"crossref","unstructured":"Matutes E, Garcia Talavera J, O'Brien M, Catovsky D. The morphological spectrum of T-prolymphocytic leukaemia. Br J Haematol.1986;64: 111-124.","DOI":"10.1111\/j.1365-2141.1986.tb07579.x"},{"key":"2020021223594809300_REF5","doi-asserted-by":"crossref","unstructured":"Matutes E, Brito-Babapulle V, Swansbury J, et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood.1991;78: 3269-3274.","DOI":"10.1182\/blood.V78.12.3269.3269"},{"key":"2020021223594809300_REF6","doi-asserted-by":"crossref","unstructured":"Soulier J, Pierron G, Vecchione D, et al. A complex pattern of recurrent chromosomal losses and gains in T-cell prolymphocytic leukemia. Genes Chromosomes Cancer.2001;31: 248-254.","DOI":"10.1002\/gcc.1141"},{"key":"2020021223594809300_REF7","doi-asserted-by":"crossref","unstructured":"Kojima K, Kobayashi H, Imoto S, et al. 14q11 abnormality and trisomy 8q are not common in Japanese T-cell prolymphocytic leukemia. Int J Hematol.1998;68: 291-296.","DOI":"10.1016\/S0925-5710(98)00074-7"},{"key":"2020021223594809300_REF8","doi-asserted-by":"crossref","unstructured":"Jackow CM, Cather JC, Hearne V, Asano AT, Musser JM, Duvic M. Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion. Blood.1997;89: 32-40.","DOI":"10.1182\/blood.V89.1.32"},{"key":"2020021223594809300_REF9","doi-asserted-by":"crossref","unstructured":"Brito-Babapulle V, Maljaie SH, Matutes E, Hedges M, Yuille M, Catovsky D. Relationship of T leukaemias with cerebriform nuclei to T-prolymphocytic leukaemia: a cytogenetic analysis with in situ hybridization. Br J Haematol.1997;96: 724-732.","DOI":"10.1046\/j.1365-2141.1997.9702605.x"},{"key":"2020021223594809300_REF10","unstructured":"Matutes E, Keeling DM, Newland AC, et al. Sezary cell-like leukemia: a distinct type of mature T cell malignancy [published erratum appears in Leukemia. 1990;4:547]. Leukemia.1990;4: 262-266."},{"key":"2020021223594809300_REF11","doi-asserted-by":"crossref","unstructured":"Vonderheid EC, Bernengo MG, Burg G, et al. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol.2002; 46: 95-106.","DOI":"10.1067\/mjd.2002.118538"},{"key":"2020021223594809300_REF12","doi-asserted-by":"crossref","unstructured":"Kim YH, Bishop K, Varghese A, Hoppe RT. Prognostic factors in erythrodermic mycosis fungoides and the Sezary syndrome. Arch Dermatol.1995; 131: 1003-1008.","DOI":"10.1001\/archderm.1995.01690210033005"},{"key":"2020021223594809300_REF13","doi-asserted-by":"crossref","unstructured":"Lima M, Almeida J, Dos Anjos Teixeira M, et al. TCRalphabeta+\/CD4+ large granular lymphocytosis: a new clonal T-cell lymphoproliferative disorder. Am J Pathol.2003;163: 763-771.","DOI":"10.1016\/S0002-9440(10)63703-0"},{"key":"2020021223594809300_REF14","doi-asserted-by":"crossref","unstructured":"Macon WR, Levy NB, Kurtin PJ, et al. Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas. Am J Surg Pathol.2001;25: 285-296.","DOI":"10.1097\/00000478-200103000-00002"},{"key":"2020021223594809300_REF15","doi-asserted-by":"crossref","unstructured":"Kussick SJ, Wood BL, Sabath DE. Mature T cell leukemias which cannot be adequately classified under the new WHO classification of lymphoid neoplasms. Leukemia.2002;16: 2457-2458.","DOI":"10.1038\/sj.leu.2402715"},{"key":"2020021223594809300_REF16","doi-asserted-by":"crossref","unstructured":"Washington LT, Huh YO, Powers LC, Duvic M, Jones D. A stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy. BMC Clin Pathol.2002;2: 5-10.","DOI":"10.1186\/1472-6890-2-5"},{"key":"2020021223594809300_REF17","doi-asserted-by":"crossref","unstructured":"Jones D, Dang NH, Duvic M, Washington LT, Huh YO. Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am J Clin Pathol.2001;115: 885-892.","DOI":"10.1309\/U1Y6-J4AG-5M4M-7AYV"},{"key":"2020021223594809300_REF18","doi-asserted-by":"crossref","unstructured":"Herling M, Teitell MA, Shen RR, Medeiros LJ, Jones D. TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin. Blood.2003;101: 5007-5009.","DOI":"10.1182\/blood-2002-10-3297"},{"key":"2020021223594809300_REF19","doi-asserted-by":"crossref","unstructured":"Gandhi V, Plunkett W, Weller S, et al. Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells. J Clin Oncol.2001;19: 2142-2152.","DOI":"10.1200\/JCO.2001.19.8.2142"},{"key":"2020021223594809300_REF20","doi-asserted-by":"crossref","unstructured":"Keating MJ, Cazin B, Coutre S, et al. Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed. J Clin Oncol.2002;20: 205-213.","DOI":"10.1200\/JCO.20.1.205"},{"key":"2020021223594809300_REF21","doi-asserted-by":"crossref","unstructured":"Apisarnthanarax N, Talpur R, Duvic M. Treatment of cutaneous T cell lymphoma: current status and future directions. Am J Clin Dermatol.2002;3: 193-215.","DOI":"10.2165\/00128071-200203030-00006"},{"key":"2020021223594809300_REF22","doi-asserted-by":"crossref","unstructured":"Apisarnthanarax N, Duvic M. Therapy options in cutaneous T-cell lymphoma. Expert Rev Anticancer Ther.2001;1: 403-420.","DOI":"10.1586\/14737140.1.3.403"},{"key":"2020021223594809300_REF23","doi-asserted-by":"crossref","unstructured":"Pekarsky Y, Hallas C, Croce CM. The role of TCL1 in human T-cell leukemia. Oncogene.2001; 20: 5638-5643.","DOI":"10.1038\/sj.onc.1204596"},{"key":"2020021223594809300_REF24","doi-asserted-by":"crossref","unstructured":"Hoyer KK, French SW, Turner DE, et al. Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma. Proc Natl Acad Sci U S A.2002; 99: 14392-14397.","DOI":"10.1073\/pnas.212410199"},{"key":"2020021223594809300_REF25","doi-asserted-by":"crossref","unstructured":"Virgilio L, Lazzeri C, Bichi R, et al. Deregulated expression of TCL1 causes T cell leukemia in mice. Proc Natl Acad Sci U S A.1998;95: 3885-3889.","DOI":"10.1073\/pnas.95.7.3885"},{"key":"2020021223594809300_REF26","doi-asserted-by":"crossref","unstructured":"Pawson R, Matutes E, Brito-Babapulle V, et al. Sezary cell leukaemia: a distinct T cell disorder or a variant form of T prolymphocytic leukaemia? Leukemia.1997;11: 1009-1013.","DOI":"10.1038\/sj.leu.2400710"},{"key":"2020021223594809300_REF27","doi-asserted-by":"crossref","unstructured":"Serra A, Estrach MT, Marti R, Villamor N, Rafel M, Montserrat E. Cutaneous involvement as the first manifestation in a case of T-cell prolymphocytic leukaemia. Acta Derm Venereol.1998;78: 198-200.","DOI":"10.1080\/000155598441521"},{"key":"2020021223594809300_REF28","doi-asserted-by":"crossref","unstructured":"Vega F, Medeiros LJ, Bueso-Ramos C, et al. Hepatosplenic gamma\/delta T-cell lymphoma in bone marrow: a sinusoidal neoplasm with blastic cytologic features. Am J Clin Pathol.2001;116: 410-419.","DOI":"10.1309\/BM40-YM6J-9T3X-MH8H"},{"key":"2020021223594809300_REF29","doi-asserted-by":"crossref","unstructured":"Sugimoto T, Imoto S, Matsuo Y, et al. T-cell receptor gammadelta T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a post-thymic immunophenotype. Ann Hematol.2001; 80: 749-751.","DOI":"10.1007\/s00277-001-0381-z"},{"key":"2020021223594809300_REF30","doi-asserted-by":"crossref","unstructured":"Dybjer A, Hellquist L, Johansson B, Rydgren L, Billstrom R. Seropositive polyarthritis and skin manifestations in T-prolymphocytic leukemia\/Sezary cell leukemia variant. Leuk Lymphoma.2000; 37: 437-440.","DOI":"10.3109\/10428190009089445"},{"key":"2020021223594809300_REF31","doi-asserted-by":"crossref","unstructured":"Matutes E, Wotherspoon AC, Parker NE, Osuji N, Isaacson PG, Catovsky D. Transformation of T-cell large granular lymphocyte leukaemia into a high-grade large T-cell lymphoma. Br J Haematol.2001;115: 801-806.","DOI":"10.1046\/j.1365-2141.2001.03220.x"},{"key":"2020021223594809300_REF32","doi-asserted-by":"crossref","unstructured":"Jones D, Dorfman DM. Phenotypic characterization of subsets of T cell lymphoma: towards a functional classification of T cell lymphoma. Leuk Lymphoma.2001;40: 449-459.","DOI":"10.3109\/10428190109097644"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/2\/328\/1700003\/zh801404000328.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/2\/328\/1700003\/zh801404000328.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:27Z","timestamp":1581552027000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/104\/2\/328\/18289\/A-systematic-approach-to-diagnosis-of-mature-Tcell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,15]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,7,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-01-0002","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,15]]}}}